arrow
M

Modesto de Candia

university of bari (aldo moro)
H指数:20
被引数:1,135

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells

通过基于结构的虚拟筛选鉴定新型假定的自泌素抑制剂,并评估其对卵巢癌和乳腺癌细胞的抗增殖特性

2026-09-080
PRE
Targeting GPR18: Structural modelling, ligand discovery, and therapeutic potential in neuroinflammatory disorders

靶向GPR18:结构建模、配体发现及其在神经炎症性疾病中的治疗潜力

2026-05-090
OAAI
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment

第一类1,3,5-三嗪衍生的双5-HT6R/FAAH调节剂,用于寻找针对伴有认知障碍的神经退行性疾病的潜在药物

2025-08-050
OA
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor

多奈哌齐样双重AChE/mao-b抑制剂的光介导的激活/失活控制和体外adme-tox谱

2025-06-010
OA
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
2024-02-192
PRE
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
2023-11-018
OAAI
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection

新型含胍基异哌啶酰胺凝血因子抑制剂对SARS CoV-2病毒感染的评价

2022-08-055
OAAI